Skin drug delivery systems are a constant source of interest because of the benefits that they offer to overcome many drawbacks associated with other modes of drug delivery (i.e. oral, intravenous, etc.). Because of the impermeable nature of the skin, designing a suitable drug delivery vehicle that penetrates the skin barrier is challenging.
Introduction
Skin is the human body's largest organ. It covers the entire body and separates the vital organs from the outside environment and serves as a protective barrier against physical, chemical and microbial attacks. Since the skin is the organ that is most exposed to the environment, the risk of damage of its integrity or the occurrence of a localized disease is very high [1] [2] .
The human skin is composed of three layers, consisting in: Stratum Corneum (SC), Epidermis and Dermis ( Fig.1) , the outer layer is the SC. The epidermis is put in contact with the dermis by so called dermoepidermis function (as a permeable membrane). The dermis is constituted by a connective tissue layer of mesenchymal origin. Finally, the inner layer is represented by the hypodermis, mainly constituted by connective tissue [3] [4] [5] [6] [7] [8] [9] [10] [11] . Skin drug delivery can be subdivided into topical and transdermal. In a topical application the drug is intended to act at skin level. This delivery is an attractive route for local and systemic treatment. Topical drug administration may be localized anywhere in the body through ophthalmic, rectal, vaginal routes and skin. The delivery of drugs onto the skin is recognized as an effective means of therapy for local dermatologic diseases such as follicle-related disorders (e.g., acne and alopecias). It can penetrate deeper into skin and hence give better absorption [12, 13] . Topical administrations have many advantages over the conventional dosage forms.
In general, they are deemed more effective and less toxic than conventional formulations due to the bilayer composition and structure. In the formulation of topical dosage forms, attempts are being made to utilize drug carriers that ensure adequate localization or penetration of the drug within or through the skin in order to enhance the local effects and minimize the systemic ones, or to ensure adequate percutaneous absorption.
Summarizing, it may be stated that the topical application of drugs offers potential advantages of delivering the drug directly to the site of action and acting for extended period of time. The drugs are intended for skin or for certain mucosal surfaces for their local action or percutaneous penetration of medicament or for their emollient or protective action.
The transdermal drug release is a variable administration route for powerful, not only low-molecular weight therapeutic agents, which has to be precise in the control of drug distribution. This release is specially recommended for many drugs that are difficult to be taken since they must be delivered slowly over a prolonged period to have a beneficial effect [7] [8] [9] [10] .
The transdermal drug administration has several interesting advantages over other systemic routes; the most interesting is the reduction of first-pass drug degradation as the liver is initially bypassed [4] . The transdermal drug delivery was mainly considered as diffusion transdermal delivery. Recently, methods of drug delivery taking into account the drug flow and the diffusion transport through the skin have been considered. The first application of these methods was described by Siegel [14] who approached insulin delivery by means of an implantable mechano-chemical pump converting changes in blood glucose concentration into a pressure pumping insulin out of the device. This pumping is possible after execution of micro-capillaries in the skin connecting the pump with the dermis, or -more generally -after an enhancement of the skin permeability. While chemical enhancers can be a successful tool for the improvement of small drug permeability through the skin, for big molecules other strategies have to be developed. Indeed, proteins and peptides transdermal administration requires the use of physical methods involving electrically based techniques (iontophoresis, electroporation, ultrasound, and photo-mechanical waves), structure-based techniques (microneedles, specially with internal jet-injection), and velocity-based techniques (jet-propulsion) [6] [7] [8] [9] [10] [15] [16] [17] [18] [19] [20] . Each of these methods leads to the aforementioned execution of micro-capillaries in the skin.
The aim of this work is to present the rheological considerations on mathematical models of drugs and drug carriers to be administered through the skin. Motivated by the results of the recent papers on the drugs delivery through the skin, the principle idea of this work is to present new mathematical models describing the flow behaviour of novel drugs and experimental verification of some of these models. Finally, for all the models under consideration three dimensional forms of their descriptions are presented which may be used to model and analyse drug flows through the connective tissue [15] [16] [17] [18] [19] [20] .
Structure of the skin delivery drugs
Topical drug administration is recommended in skin diseases such as atopic dermatitis, psoriasis and ichthyosis; it is also advised in anti-inflammatory and in analgesic therapy [21, 22] .
In general, the topic and transdermal drug delivery are applied in dermatology, cosmetology, internal medicine and oncology [4] .
Several pharmaceuticals such as creams, ointments, pastes and gels have been used for topical drug delivery, while suspensions, emulsions and also gels have been used for transdermal drug delivery [7] .
Creams are two-phase systems containing oil and water, one of which is dispersed in the other in the form of microscope droplets (an emulsion). In order to achieve a homogeneous dispersion of the droplets, emulsifiers are added to the cream; some of these emulsifiers can cause an irritation of the skin [22] . In ointments the carrier fluid is more sticky than the water or oil and most frequently it is white vaseline or/and liquid paraffin [9] .
Pastes are two-phase dilate systems with emulsifiers acting on droplets or solid particles; the carriers are: wax and its solutions [10] .
Suspensions are two-phase systems of solid or fluid particles dispersed in carrier fluids such as water or oil [10] .
Emulsions are two-phase systems containing any kind of fluids dispersed in water; in emulsions the concentration of dispersed fluids is less than that in creams. We may differentiate microemulsions and nanoemulsions [7] . All these pharmaceuticals mentioned above may be -in particular cases -poly-phase dispersions and may be enriched into other drug agents.
Gels are defined as semisolid systems, which exhibit an external solvent phase. They are hydrophobic or hydrophilic in nature, and are immobilized within the spaces available of a threedimensional network structure [23] [24] [25] . Gels principally consist of a fluid solvent with the minority component forming a semisolid matrix; this matrix being a gelling agent such as carbomer or natural gum (e.g.: xantam or guar gum) is dispersed in purified water or in organic solvent to make a uniform dispersion. Gels, having more water than creams and ointments, permit greater dissolution of drugs and facilitate their migration through the vesicle and by their high water content they can hydrate the skin retaining a significant amount of transdermal water [26, 27] . One differentiates essentially two types of gels according to the nature of their liquid phase, namely: hydrogels containing water and organogels (oleogels) containing organic solvent.
Recently, some new trends and terminologies of gel systems in skin drug delivery have been noted. They are as follows: niosame and proniosame gels, emulgels, bigels, aerogels and xerogels [28] .
Niosomes are liposomes consisting of a nonionic surfactant. They may be either unilamellar or multi-lamellar vesicles that are capable of carrying both hydrophilic and hydrophobic drugs.
Proniosomes are liquid crystalline compact niosomal hybrids, which may be converted into niosomes upon hydration.
Emulgels are combinations of an emulsion and a gel. They may also include microemulgels and nano-emulgels, which reduce the diffusion barrier of the stratum corneum and show acceptable physical properties drug release and low skin irritations.
Bigels are topical formulations that are obtained by combining a hydrogel and an organogel, therefore they possess characteristics of both gels such as the cooling effect, enhancement of skin hydration, moisturizing, emollient effect, easy spreadability, and water-washability upon application to the skin.
Aerogels and xerogels are inorganic gels, since both are composed of silica but they undergo different drying procedures. If a wet silica gel is dried at normal pressure, it significantly shrinks and results in a dense material with a relatively small pores size known as a xerogel. In the case of a supercritical drying, shrinkage is avoided, the unusually porous structure is preserved, and the result is known as an aerogel.
Rheological properties of the drugs and drug carriers
Liquid drug carriers and pharmaceuticals are prepared from different substances having diverse physico-chemical and rheological properties. Most pharmaceutical and cosmetic processes such as new ingradient selections, formulation preparations, material packing and self storage are closely associated with complex flows of substances. The kind of applications and acceptance of pharmaceutical and cosmetics are also greatly dependent on the flow properties of the final products [29] . Therefore, knowledge of the rheological properties of pharmaceutical and cosmetic substances becomes an essential key to improve processing efficiency as well as to develop consumer acceptable final products.
Drug materials vary in consistency from solid to fluid state. An important category is to comprised of semi-solid products which are the most difficult substances to attempt a rheological characterization because they combine both solid-like and fluid-like properties within the same material. Widely used pharmaceutical and cosmetic products belonging to this category are ointments, creams, pastes and gels; all of which can be classified as semi-fluid materials.
Rheological measurements of these materials should be made for a number of reasons including [30] [31] [32] [33] [34] [35] [36] :
 to understand the rheological nature of a system,  to perform quality control of raw materials, final products and manufacturing processes (mixing, pumping, packing and filling),  to study the effect parameters (formulation, storage time, temperature) on the quality of a final product,  to assess a product with regard to actual usage such as spreading and adherence to the skin, removal from a tube or a jar.
One dimensional models of rheologically complex drug carriers
Taking into account the reasons mentioned above, the following one -dimensional model describing the rheological properties of pharmaceutical drug carriers [37] can be proposed:
which is used to describe the flow properties of such pharmaceutical substances as creams, emulsions, ointments and pastes; here:  -is the shear stress, 0  -is the yield shear stress,   -is s the hear strain rate,  -is the plastic viscosity, , m n -are power exponents (material parameters). Note that by a reduction of coefficients in the Shulman model the formulae describing simpler models of the fluid can be obtained such as:
The Ostwald-de Waele model is frequently called the power-law model.
which is applied to describe the flow properties of emulsions and suspensions here: 0  -is the shear viscosity, n-is power exponent. There are some models well describing the rheological drug properties which after suitable reduction of material parameters will be similar to the Sisko model. These models are [37] : which may be used to describe the flow properties of micro-and nano-emulsions and suspensions. Similar models are given below [37] :
Ree-Eyring
Note that all the above mentioned formulae -under some conditions -may be used for describing the flow properties of gels and emulgels.
The gel being a mixed system of semisolid and semifluid substances often demonstrates viscoelastic behaviour. To describe the flow properties of such a system it is common to use the models of viscoelastic fluids.
The first of these models is usually not presented in the one dimensional notation but only to demonstrate its principle we will introduce this description [37]  
where   -is the velocity of the shear strain rate, , 
where G is a Hookean elastic modulus.
Three-dimensional models of rheologically complex drug carriers
To find three-dimensional forms of the stress tensor T , corresponding to the above given onedimensional forms of  , we may use the generalization whose basis is as follows [37] :
where
here p is the pressure,  is the so-called extra-stress tensor, 1
A is the first kinematic tensor of Rivlin-
where A is a square root from the second invariant of 1
A .
All equations of type
are called constitutive equations and generally they represent functional relations between the forces acting on the medium and the quantities describing the motion that may be realized, some of extra-stress tensors are presented in Tab.1. 
is a square root from the second invariant of Λ . The constitutive relation for the second grade viscoelastic fluid of Rivlin-Ericksen is given as follows [37]
where 1 is the unit tensor, ,   and  are shear viscosity and material coefficient, respectively, and ,
2
A A are the first two Rivlin-Ericksen tensors defined by
,
T denotes the transpose of the tensor matrix.
The constitutive relation for the Maxwell fluid is given as follows [37]
where  is a new material coefficient having a dimension of / G  or dimension of time t. Another similar viscoelastic fluid is a Jeffreys fluid for which the constitutive equation has the form
where , 1 2   are material coefficient having a dimension of time t.
Constitutive equations for generalized viscoelastic fluids
Many fluids of medical interest appear to exhibit yield behaviour, where flow occurs only when the imposed stress exceeds a critical yield stress. To describe the most general rheological behaviour of such a viscoplastic fluid the non-linear model of Shulman (3.36) may be used; it is suitable to present this model in the following form
where M is called a viscosity function.
To obtain a model that does exhibit both viscoplastic and viscoelastic behaviour Walicki and Walicka proposed the following two constitutive equations for generalized second grade fluids [37]
Considering some recent experimental and theoretical results Walicka [37] 
Note that these generalized second grade fluids may be used to describe the flows of drugs and drug carriers being emulsions, suspensions, and even lipid based lyotropic liquid crystals [38, 39] . These crystals can be V and 2 H are the most important and recently they have received much attention due to their highly ordered internal structure, which offers the great potential as a slow release matrix for active pharmaceutical ingredients with various size and polarities [40] [41] [42] [43] [44] . Cubic and hexagonal liquid crystals are often formed by the addition of certain amphiphilic lipids in an aqueous environment (e.g., they can be prepared by simply blending lipid and aqueous phase by vortex). When both these liquid crystals are dispersed into nanoparticles with excess water with addition of certain stabilizers, they form stable colloidal dispersions which are termed cubosomes and hexosomes, respectively. Analysing the latest reports on the rheological behaviour of lyotropic liquid crystals presented in the papers [40] [41] [42] [43] [44] , it seems that novel descriptions relating to viscoelastic fluids of Maxwell and Jeffreys type being drug carriers may be provided. These descriptions consist in changing the simple material derivatives 
where symbol  denotes so called Oldroyd general derivative (see Eq.(A.11) in Appendix).
Let us still consider the specific models of viscoelastic fluids being drug carriers called fractional models. In order to describe the viscoelastic properties of fluids in various medical fields more exactly, equations with besides the constitutive even complex derivatives, we would like to introduce, fractional time derivatives [37] . Then the constitutive equation of a viscoelastic fluid for the fractional Maxwell model has the form
In the above expression   
in which     is a Gamma function. It is noted that for 1   , Eq.(4.14) reduces to a Maxwell model given by Eq. (3.40) . Similarly, the fractional model for a Jeffreys fluid has the form
where  and  are the fractional parameters such that 0 1      and    ; the derivative operator according to Eq.(A.1) is expressed as follows 
Rheometric measurements
All rheological measurements serve to determine the material coefficients such as:
, , , , , , , G      for other fluids of Maxwell or Jeffreys type. Different methods which are used to determine and measure these material parameters are described in [45] [46] [47] [48] . Generally, instruments named rheometers are used for these measurements. Instruments which are limited in their use only for the measurements of the viscous flow behaviour of fluids are called viscometers. The action of viscometers consists in an analysis of shear induced flow in fluids which can occur in four model cases [45] :
 flow between two parallel discs, when one disc moves and the other is stationary;  flow in the annular gap between two concentric cylinders, when one is assumed to be stationary while the other rotates;  flow through pipes, tubes or capillaries;  flow between two parallel discs or between cone and disc sensor systems when one is stationary and the other rotates.
Method and materials
All rheological analyses were performed for some typical commercial creams and ointments with a controlled-stress rheometer VT550 (Haake, Karlsruhe-Germany) and RheoWin 4.50 software, with cone -and -disc sensor system of 28 mm diameter with a gap of 50 m  (height of removed tip in truncated cone) and cone angle 1    . The measurements will be limited only to find so called flow curves being a graphical form of the expression
The shear rate c   is equal to [45] , tan Examining the descending flow curves of the rheograms shown in Figs 2-4 it can be seen that all drugs present a non-Newtonian character at both temperatures. Analyzing these curves it can be observed that the tested pharmaceuticals may be numbered both among the pseudoplastic substances and the viscoplastic substances. As it is noted in Tabs 4 and 5, the yield stress 0  decreases with the increasing temperature; Hydrocortisonum is here an exception. The yield stress increases with the increasing diclofenac concentration (compare Diclofenac 10 mg with Voltaren Max containing 23 mg of diclofenac).
Plastic viscosity  and flow index n follow the same trends without an exception as the yield stress with respect to the temperature changes.
Conclusions
In this paper, we have focused on an analytical description of rheological properties of the drugs for topical and transdermal delivery. For this purpose we considered rheological models of drugs having a different consistency: suspension, gel, cream etc, etc. First, the simplest models of fluids such as pseudoplastic and viscoplastic fluids represented by the Shulman models, then more complicated models of viscoplastic fluids such as Maxwell and Jeffreys models were considered, and finally, fractional models of viscoelastic fluids were analysed. It seems that the latter may be used to describe the rheological behaviour of such drug carriers as lyotropic liquid crystals.
Knowledge of rheological behaviour of pharmaceuticals designed for topical and transdermal application is very important. The knowledge can be used at technological level e.g. by an insertion of active or auxiliary substances and at therapeutical level when the rheological parameters can be correlated with composition of drugs and therefore with their consistency, bioavailability and also their stability.
Rheological testing performed on the same commercial pharmaceuticals showed that the all formulations had a non-Newtonian pseudoplastic or viscoplastic behaviour at both considered temperatures. 
